SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA077696 (CHARTWELL MOLECULAR)
SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA077696 (CHARTWELL MOLECULAR) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN SUCCINATE; Active ingredients: SUMATRIPTAN SUCCINATE; Application number: ANDA077696.
| Brand name | SUMATRIPTAN SUCCINATE |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Application number | ANDA077696 |
| Sponsor | CHARTWELL MOLECULAR |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 3 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →